UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Inquiry Search clinical trials


Unique ID issued by UMIN UMIN000009607
Receipt No. R000011266
Scientific Title The double-blind, randomised controlled phase II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with head and neck mucosal melanoma followed by standard therapy.
Date of disclosure of the study information 2013/04/01
Last modified on 2020/08/15 14:17:19

No. Disposal Last modified on Item of update
1 Insert 2012/12/21 16:52:26
2 Update 2013/06/27 07:55:18 Recruitment status
3 Update 2020/08/15 14:17:19 Recruitment status
Date of IRB
Last follow-up date

Contact us.